Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study Combining Etanercept and Short Courses of Narrow-Band UVB in Patients With Psoriasis Vulgaris

NCT00640393 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00640393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study Combining Etanercept and Short Courses of Narrow-Band UVB in Patients With Psoriasis Vulgaris
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
March 31, 2010
Enrollment
99 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris